A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus

• Autores principales: Bang Sun-Hwi (Autor), Yoon Jeung-Won (Autor), Cho Chong-Kwan (Autor), Shin Ji-Eun (Autor), Lee Yeon-Weol (Autor), Yoo Hwa-Seung (Autor)
• Formato: Libro
• Publicado: Korean Pharmacopuncture Institute, 2012-06-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background and Objectives: Non-small-cell lung cancer (NSCLC) represents approximately 80% of all lung cancers. Unfortunately, at their time of diagnosis, most patients have advanced to unresectable disease with a very poor prognosis. The oriental herbal medicine HangAm-Plus (HAP) has been developed...